Pintumomab

Jump to: navigation, search
Pintumomab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Pintumomab

Articles

Most recent articles on Pintumomab

Most cited articles on Pintumomab

Review articles on Pintumomab

Articles on Pintumomab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pintumomab

Images of Pintumomab

Photos of Pintumomab

Podcasts & MP3s on Pintumomab

Videos on Pintumomab

Evidence Based Medicine

Cochrane Collaboration on Pintumomab

Bandolier on Pintumomab

TRIP on Pintumomab

Clinical Trials

Ongoing Trials on Pintumomab at Clinical Trials.gov

Trial results on Pintumomab

Clinical Trials on Pintumomab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pintumomab

NICE Guidance on Pintumomab

NHS PRODIGY Guidance

FDA on Pintumomab

CDC on Pintumomab

Books

Books on Pintumomab

News

Pintumomab in the news

Be alerted to news on Pintumomab

News trends on Pintumomab

Commentary

Blogs on Pintumomab

Definitions

Definitions of Pintumomab

Patient Resources / Community

Patient resources on Pintumomab

Discussion groups on Pintumomab

Patient Handouts on Pintumomab

Directions to Hospitals Treating Pintumomab

Risk calculators and risk factors for Pintumomab

Healthcare Provider Resources

Symptoms of Pintumomab

Causes & Risk Factors for Pintumomab

Diagnostic studies for Pintumomab

Treatment of Pintumomab

Continuing Medical Education (CME)

CME Programs on Pintumomab

International

Pintumomab en Espanol

Pintumomab en Francais

Business

Pintumomab in the Marketplace

Patents on Pintumomab

Experimental / Informatics

List of terms related to Pintumomab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Pintumomab is a mouse monoclonal antibody and which it is used to treat cancer. Pintumomab has a radioisotope, technetium-99m Tc.


Cost Effectiveness of Pintumomab

| group5 = Clinical Trials Involving Pintumomab | list5 = Ongoing Trials on Pintumomab at Clinical Trials.govTrial results on PintumomabClinical Trials on Pintumomab at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Pintumomab | list6 = US National Guidelines Clearinghouse on PintumomabNICE Guidance on PintumomabNHS PRODIGY GuidanceFDA on PintumomabCDC on Pintumomab


| group7 = Textbook Information on Pintumomab | list7 = Books and Textbook Information on Pintumomab


| group8 = Pharmacology Resources on Pintumomab | list8 = AND (Dose)}} Dosing of PintumomabAND (drug interactions)}} Drug interactions with PintumomabAND (side effects)}} Side effects of PintumomabAND (Allergy)}} Allergic reactions to PintumomabAND (overdose)}} Overdose information on PintumomabAND (carcinogenicity)}} Carcinogenicity information on PintumomabAND (pregnancy)}} Pintumomab in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Pintumomab


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Pintumomab | list9 = AND (pharmacogenomics)}} Genetics of PintumomabAND (pharmacogenomics)}} Pharmacogenomics of PintumomabAND (proteomics)}} Proteomics of Pintumomab


| group10 = Newstories on Pintumomab | list10 = Pintumomab in the newsBe alerted to news on PintumomabNews trends on Pintumomab


| group11 = Commentary on Pintumomab | list11 = Blogs on Pintumomab

| group12 = Patient Resources on Pintumomab | list12 = Patient resources on PintumomabDiscussion groups on PintumomabPatient Handouts on PintumomabDirections to Hospitals Treating PintumomabRisk calculators and risk factors for Pintumomab


| group13 = Healthcare Provider Resources on Pintumomab | list13 = Symptoms of PintumomabCauses & Risk Factors for PintumomabDiagnostic studies for PintumomabTreatment of Pintumomab

| group14 = Continuing Medical Education (CME) Programs on Pintumomab | list14 = CME Programs on Pintumomab

| group15 = International Resources on Pintumomab | list15 = Pintumomab en EspanolPintumomab en Francais

| group16 = Business Resources on Pintumomab | list16 = Pintumomab in the MarketplacePatents on Pintumomab

| group17 = Informatics Resources on Pintumomab | list17 = List of terms related to Pintumomab


}}



Linked-in.jpg